Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle

Int J Cardiol. 2021 Jul 1:334:28-29. doi: 10.1016/j.ijcard.2021.04.035. Epub 2021 Apr 26.

Authors

Monica Verdoia¹, Lucia Barbieri², Giuseppe De Luca³

Affiliations

¹ Division of Cardiology Ospedale degli Infermi, ASL Biella, Italy; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
² Division of Cardiology, Policlinico of Milan, Milan, Italy.
³ Division of Cardiology, AOU Maggiore della Carità, Novara, Italy; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. Electronic address: giuseppe.deluca@maggioreosp.novara.it.

PMID: 33915235
DOI: 10.1016/j.ijcard.2021.04.035

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome* / diagnosis
Acute Coronary Syndrome* / drug therapy
Acute Coronary Syndrome* / epidemiology
Aged
Alleles
Clopidogrel
Cytochrome P-450 CYP2C19
Humans
Platelet Aggregation Inhibitors* / adverse effects
Ticagrelor

Substances

Platelet Aggregation Inhibitors
Clopidogrel
CYP2C19 protein, human
Cytochrome P-450 CYP2C19
Ticagrelor